A Retrospective Analysis of Outcome in Melanoma Differentiation-Associated Gene 5-Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus.
Li FanWenting LyuHuarui LiuHanyi JiangLulu ChenYin LiuYi ZhuangMei HuangMin CaoHourong CaiYonglong XiaoJinghong DaiPublished in: The Journal of rheumatology (2022)
Our observational study showed that TOF use might have a potential effect on improving the outcomes of MDA5-ILD. Future clinical trials are needed to assess the long-term efficacy and tolerability of TOF.
Keyphrases
- interstitial lung disease
- rheumatoid arthritis
- systemic sclerosis
- mass spectrometry
- ms ms
- clinical trial
- idiopathic pulmonary fibrosis
- open label
- current status
- copy number
- genome wide
- breast cancer cells
- human health
- double blind
- randomized controlled trial
- gene expression
- climate change
- adipose tissue
- dna methylation
- skin cancer
- signaling pathway
- cell death
- skeletal muscle
- risk assessment
- glycemic control